Eptifibatide
Also known as: integrilin research, cyclic RGD antiplatelet
Cyclic RGD-based GP IIb/IIIa inhibitor studied in platelet aggregation and acute coronary models.
Quick Reference
Eptifibatide - Research Images
PSO vial render · Scientific images from Wikipedia · Tap to enlarge
Overview
Antiplatelet drug
Eptifibatide, is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a disintegrin protein found in the venom of the southeastern pygmy rattlesnake. It belongs to the class of the arginine-glycine-aspartate-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.
Mechanism of Action
Eptifibatide, is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a disintegrin protein found in the venom of the southeastern pygmy rattlesnake. It belongs to the class of the arginine-glycine-aspartate-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.
What Researchers Are Saying
Community Reports - Not Medical Advice
The following is aggregated from public forums, Reddit, and research communities. These are anecdotal reports from researchers only - not verified clinical data and not a recommendation of any kind.
Eptifibatide (also known as integrilin research, cyclic RGD antiplatelet) is studied within the peptide research community. Cyclic RGD-based GP IIb/IIIa inhibitor studied in platelet aggregation and acute coronary models.
Last updated October 28, 2026
Research status: active. Eptifibatide appears across peptide research forums and academic literature. Researchers note this compound falls in the other category.
Last updated October 28, 2026
What Do You Think of This Peptide?
Share your opinion or research experience with Eptifibatide. Comments are reviewed before appearing.